Top news of the week: 15.09.2020.

Biotechnology, Finance, Hedge fund, Samuel Adams, Chapter 11, Title 11, United States Code, Drug

Startups

On Sep 9, 2020
@BiotechWorld shared
After Bind bankruptcy, Hirsch once again helms a biotech, landing at C4 https://t.co/X5UL8BwhaB https://t.co/FhXX9A25Oq
Open

After Bind bankruptcy, Hirsch once again helms a biotech, landing at C4

After Bind bankruptcy, Hirsch once again helms a biotech, landing at C4

When CEO and president at Bind Therapeutics, Andrew Hirsch had to swing the ax to his workforce, file for bankruptcy and in the end sell off its remaining assets to Pfizer.

On Sep 9, 2020
@asenkut shared
Incredible to see stellar execution by @RecursionChris & his team @RecursionPharma announcing a $239M raise along with a major partnership w @Bayer for AI drug discovery - we are proud to continue our support w @speechu leading https://t.co/ctvvjMJSkc
Open

Recursion Secures $239 Million in Equity Financing to Advance Technology-Enabled Drug Discovery Platform and Pipeline

Recursion Secures $239 Million in Equity Financing to Advance Technology-Enabled Drug Discovery Platform and Pipeline

− Proceeds to support Recursion’s development of its broad clinical-stage pipeline and expansion of the capabilities of its drug discovery platform − − Series D financing led by …

On Sep 10, 2020
@Forbes shared
Recursion Pharmaceuticals raised $239 million and partnered with Bayer for AI drug discovery https://t.co/MUnWSdNFCM https://t.co/g3BfVSQQzY
Open

Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery

Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery

The Utah-based biotech company’s agreement with Bayer is potentially worth over $1 billion.

On Sep 10, 2020
@big4bio shared
Learn how to make an impact with your research: https://t.co/XXJa4ye7Nb
Open

How To Increase Visibility for Your Researchers & Your Science

How To Increase Visibility for Your Researchers & Your Science

How do you propel science forward in between discoveries? Or when the lab is closed? How about when researchers are remote? You become your own research publishing platform. This ...

On Sep 10, 2020
@WSJVC shared
Flagship Pioneering, a life sciences company-creation firm, has launched another biotech startup, Generate Biomedicines Inc. https://t.co/XaL1fWgVbZ
Open

Flagship Pioneering Hatches a New Biotech Startup, Generate Biomedicines

Flagship Pioneering Hatches a New Biotech Startup, Generate Biomedicines

Flagship has provided more than $50 million to the developer of biological drugs.

On Sep 10, 2020
@ForbesTech shared
Synthetic biology startups raised $3 billion in the first half of 2020 https://t.co/hSVDNSv92i By @johncumbers https://t.co/Xc3yHbeAaC
Open

Synthetic Biology Startups Raised $3 Billion In The First Half Of 2020

Synthetic Biology Startups Raised $3 Billion In The First Half Of 2020

While Covid-19 slowed the startup economy in the first half of 2020, the bioeconomy continued to power ahead. Fifty-six synthetic biology companies pulled in just over $3 billion of equity ...

On Sep 8, 2020
@Forbes shared
Newcomers: These 18 billionaires have joined The #Forbes400 list in 2020 https://t.co/6GfIPzXk81 https://t.co/dla8qKZ6tC
Open

Newcomers: These 18 Billionaires Join The Forbes 400 List In 2020

Newcomers: These 18 Billionaires Join The Forbes 400 List In 2020

Despite the pandemic, multibillion-dollar fortunes are still being minted in America. From Zoom founder Eric Yuan to biotech pioneer Alice Schwartz, meet the newest members of Forbes annual ...

On Sep 9, 2020
@Forbes shared
From #Forbes400 members like Bill Gates to celebrities like Will Smith and Jada Pinkett Smith, here are the nation’s most influential impact investors: https://t.co/xqzXnwtoYP https://t.co/mmfw2HrX8d
Open

Dustin Moskovitz & Cari Tuna

Dustin Moskovitz & Cari Tuna

From Forbes 400 members like Bill Gates to celebrities like Will Smith and Jada Pinkett Smith, here are the nation’s most influential impact investors.